Madurella mycetomatis is not susceptible to the echinocandin class of antifungal agents

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 6, 2010, Pages 2738-2740

  Van De Sande, Wendy W J ^a   Fahal, Ahmed H ^b   Bakker Woudenberg, Irma A J M ^a   Van Belkum, Alex ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF KHARTOUM   (Sudan)

Author keywords

[No Author keywords available]

Indexed keywords

ANIDULAFUNGIN; ANTIFUNGAL AGENT; CASPOFUNGIN; ECHINOCANDIN; KETOCONAZOLE; MICAFUNGIN;

ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; ASPERGILLUS FUMIGATUS; CONTROLLED STUDY; EUMYCETOMA; FUNGUS ISOLATION; MADURELLA MYCETOMATIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

ANTIFUNGAL AGENTS; ASPERGILLUS FUMIGATUS; DRUG RESISTANCE, FUNGAL; ECHINOCANDINS; HUMANS; LIPOPEPTIDES; MADURELLA; MICROBIAL SENSITIVITY TESTS; MYCETOMA;

EID: 77952656095     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01546-09     Document Type: Article

References (12)

1. Ahmed, A. O., W. W. van de Sande, W. van Vianen, A. van Belkum, A. H. Fahal, H. A. Verbrugh, and I. A. Bakker-Woudenberg. 2004. In vitro susceptibilities of Madurella mycetomatis to itraconazole and amphotericin B assessed by a modified NCCLS method and a viability-based 2,3-bis(2-methoxy-4- nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT) assay. Antimicrob. Agents Chemother. 48: 2742-2746.
2. CLSI/NCCLS. 2002. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved standard, vol.22. National Committee for Clinical Laboratory Standards, Wayne, PA.
3. Kahn, J. N., M. J. Hsu, F. Racine, R. Giacobbe, and M. Motyl. 2006. Caspofungin susceptibility in Aspergillus and non-Aspergillus molds: inhibition of glucan synthase and reduction of beta-D-1,3 glucan levels in culture. Antimicrob. Agents Chemother. 50:2214-2216.
4. Katiyar, S. K., and T. D. Edlind. 2009. Role for Fks1 in the intrinsic echinocandin resistance of Fusarium solani as evidenced by hybrid expression in Saccharomyces cerevisiae. Antimicrob. Agents Chemother. 53:1772-1778.
5. Maligie, M. A., and C. P. Selitrennikoff. 2005. Cryptococcus neoformans resistance to echinocandins: (1,3)beta-glucan synthase activity is sensitive to echinocandins. Antimicrob. Agents Chemother. 49:2851-2856.
6. Odabasi, Z., V. L. Paetznick, J. R. Rodriguez, E. Chen, and L. Ostrosky-Zeichner. 2004. In vitro activity of anidulafungin against selected clinically important mold isolates. Antimicrob. Agents Chemother. 48:1912-1915.
7. Perlin, D. S. 2007. Resistance to echinocandin-class antifungal drugs. Drug Resist. Updat. 10:121-130.
8. Shedletzky, E., C. Unger, and D. P. Delmer. 1997. A microtiter-based fluorescence assay for (1,3)-beta-glucan synthases. Anal. Biochem. 249:88-93.
9. van de Sande, W. W., R. Gorkink, G. Simons, A. Ott, A. O. Ahmed, H. Verbrugh, and A. van Belkum. 2005. Genotyping of Madurella mycetomatis by selective amplification of restriction fragments (amplified fragment length polymorphism) and subtype correlation with geographical origin and lesion size. J. Clin. Microbiol. 43:4349-4356.
10. van de Sande, W. W., A. Luijendijk, A. O. Ahmed, I. A. Bakker-Woudenberg, and A. van Belkum. 2005. Testing of the in vitro susceptibilities of Madurella mycetomatis to six antifungal agents by using the Sensititre system in comparison with a viability-based 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5- [(phenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT) assay and a modified NCCLS method. Antimicrob. Agents Chemother. 49:1364-1368.
11. van de Sande, W. W. J., M. Tavakol, W. van Vianen, and I. A. J. M. Bakker-Woudenberg. 2010. The effects of antifungal agents to conidial and hyphal forms of Aspergillus fumigatus. Med. Mycol. 48:48-55.
12. Zaas, A. K. 2008. Echinocandins: a wealth of choice-how clinically different are they? Curr. Opin. Infect. Dis. 21:426-432.